Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 7/20 | 0.43 |
| ▸ | F2 | P00734 | 3/20 | 0.43 |
| ▸ | CTSG | P08311 | 2/20 | 0.43 |
| ▸ | TGM2 | P21980 | 10/20 | 0.41 |
| ▸ | F13A1 | P00488 | 9/20 | 0.41 |
| ▸ | TGM1 | P22735 | 9/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | TGM3 | Q08188 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6624122 | 0.89 | ELANE (0.52) | ELANEF2CTSGTGM2F13A1 | |
| SCHEMBL6618855 | 0.89 | ELANE (0.52) | ELANEF2CTSGTGM2F13A1 | |
| SCHEMBL6621004 | 0.86 | ELANE (0.45) | ELANEF2CTSGTGM2F13A1 | |
| SCHEMBL6616802 | 0.85 | ELANE (0.42) | ELANEF2CTSGTGM2F13A1 | |
| SCHEMBL6622226 | 0.84 | ELANE (0.42) | ELANEF2CTSGNPC1RAB9A | |
| SCHEMBL6618188 | 0.81 | ELANE (0.58) | ELANEF2CTSGTGM2F13A1 | |
| SCHEMBL6621227 | 0.80 | ELANE (0.43) | ELANEF2CTSGTGM2F13A1 | |
| SCHEMBL6620330 | 0.80 | ELANE (0.43) | ELANEF2CTSGTGM2F13A1 | |
| SCHEMBL6620056 | 0.79 | ELANE (0.46) | ELANEF2CTSGTGM2F13A1 | |
| SCHEMBL6620766 | 0.79 | ELANE (0.42) | ELANEF2CTSGTGM2F13A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0891362-B1 | PYRROLOPYRROLONE DERIVATIVES AS INHIBITORS OF NEUTROPHIL ELASTASE | GLAXO GROUP LTD (GB) | 2004-03-17 | — | — | EP | disclosed |
| US-6215002-B1 | CYCLIZATION, DEBLOCKING, DEPROTECTION, SULFONATION, CONDENSATION, AMIDATION; ANTIINFLAMMATORY AGENTS; RESPIRATORY SYSTEM DISORDERS | GLAXO WELLCOME INC. | 2001-04-10 | — | — | US | disclosed |
| US-6057457-A | ENZYME INHIBITORS FOR PROTEASE OR ENZYMES OF HYDROLYSIS | GLAXO WELLCOME INC. (US) | 2000-05-02 | — | — | US | disclosed |